Draft:Neuronostatin

  • Comment: Link this to Somatostatin, including some more text about how Neuronostatin is related to Somatostatin. Also, add all the information available to the infobox. Newystats (talk) 09:09, 22 February 2026 (UTC)


{{Infobox protein 

| name = Neuronostatin
| AltNames =
| image = 
| width = 
| caption = 
| Symbol = NST
| AltSymbols =
| IUPHAR_id = 5654
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| CAS_number = 1096485-24-3
| CAS_supplemental = 
| DrugBank = 
| EntrezGene = 
| HGNCid = 11329
| OMIM = 182450, referenced
| PDB = 
| RefSeq = 6750, associated with SST
| UniProt = 
| ECnumber = 
| Chromosome = 3 
| Arm = q
| Band = 27.3
| LocusSupplementaryData = 
| Wikidata =
 }}

Neuronostatin (abbreviated as NST) is a peptide hormone that may regulate portions of the endocrine system via interactions with G protein coupled receptor..[1]

Neuronostatin is an alternative cleavage product of the preproprotein encoded by the somatostatin (SST) gene. Proteolytic processing of this precursor yields two distinct neuropeptides, with the specific products determined by tissue-dependent post-translational mechanisms. Neuronostatin is a linear, C-terminally amidated peptide that exists in forms of 13 or 19 amino acids in length.[1][2] In contrast, somatostatin, another peptide derived from the same precursor, is structurally distinct, forming cyclic peptides of 14 or 28 amino acids. [2] These differences arise from variations in cleavage sites and subsequent peptide modification, resulting in neuropeptides with unique amino acid sequences and conformations. Neuronostatin and somatostatin also differ in their biological distribution and relative abundance. Various tissues have been shown to express differing ratios of these peptides, reflecting tissue-specific regulation of SST gene processing and suggesting distinct physiological roles for each cleavage product. [2]

Amino acid sequence alignment chart of SST and its cleavage products.

Neuronostatin has been associated with impaired memory[3], increased Aβ presence and aggravated Aβ pathologies[4][5], kidney function[6] and breast/prostate cancer metastasis[7][8]

Functions

Neuronostatin signals through the G protein Couple receptor 107(GPR107).[1]

Neural Tissues

Neuronostatin binds to monomeric Aβ1-42 and increases the presence of Aβ plaques within the cortex and hippocampus of APP/PS1 mice.[4]. Neuronostatin also affects proliferation rates and metabolism within neuronal cells via activation of GPR107 and PKA[4][5]

Peripheral Tissues

Neuronostatin/GPR107 signaling is associated with regulation of COL4 within both breast cancer and kidney tissues, where Neuronostatin/GPR107 reduces expression of COL4.[7][6]. In breast cancer, this reduction in COL4 generates enlarged pores within the extracellular matrix that allow for increase breast cancer migration and proliferation, leading to increased rates of metastasis[7]. Neuronostatin and GPR107 have similarly been linked to increased rates of migration within prostate cancer[8]. Within kidney tissues, Neuronostatin/GPR107 reduces thickening/remodeling of the glomerular basement membrane by reducing COL4 deposition and improves features of diabetic nephropathy[6]

Additional features of Neuronostatin signaling include regulation of cardiomyocytes; Neuronostatin depresses cardiomyocyte function by affecting [Ca2+]i responses and regulating the expression of calcium regulating proteins[9]

References

  1. ^ a b c Yang, Shaobin; Zhao, Xiaoqian; Du, Yaqin; Yu, Peng (2022-08-01). "Emerging functions of neuronostatin in physiology, pathology, and potential therapeutics". Neuropeptides. 94: 102257. doi:10.1016/j.npep.2022.102257. ISSN 0143-4179.{{cite journal}}: CS1 maint: article number as page number (link)
  2. ^ a b c Samson, Willis K.; Zhang, Jian V.; Avsian-Kretchmer, Orna; Cui, Kai; Yosten, Gina L. C.; Klein, Cindy; Lyu, Rong-Ming; Wang, Yong Xiong; Chen, Xiang Qun; Yang, Jun; Price, Christopher J.; Hoyda, Ted D.; Ferguson, Alastair V.; Yuan, Xiao-bin; Chang, Jaw Kang (2008-11-14). "Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions". The Journal of Biological Chemistry. 283 (46): 31949–31959. doi:10.1074/jbc.M804784200. ISSN 0021-9258. PMC 2581552. PMID 18753129.
  3. ^ Yang, Shaobin; Shao, Tingji; Yu, Peng; Cao, Ruidong; Zhang, Mingyu; Wen, Kang; Fan, Maorong; He, Bosheng (2019-05-17). "Neuronostatin promotes soluble Aβ1-42 oligomers –induced spatial learning and memory impairments in mice". Behavioural Brain Research. 364: 62–74. doi:10.1016/j.bbr.2019.01.047. ISSN 0166-4328.
  4. ^ a b c Yang, Shaobin; Tang, Qi; Zhang, Yimeng; Du, Yaqin; Zhao, Xiaoqian; Mei, Fangting; Li, Yanhong (2024-11-01). "Neuronostatin regulates neuronal function and energetic metabolism in Alzheimer's disease in a GPR107-dependent manner". Neuropharmacology. 258: 110090. doi:10.1016/j.neuropharm.2024.110090. ISSN 0028-3908.{{cite journal}}: CS1 maint: article number as page number (link)
  5. ^ a b Yang, Shaobin; Zhou, Feng; Ma, Mei; Yuan, Yaqin; Zhao, Shengyou; Yu, Peng (2020-10-01). "Neuronostatin Promotion Soluble Aβ1-42 Oligomers: Induced Dysfunctional Brain Glucose Metabolism in Mice". Neurochemical Research. 45 (10): 2474–2486. doi:10.1007/s11064-020-03106-y. ISSN 1573-6903.
  6. ^ a b c Xu, Deping; Tong, Ziwen; Yang, Ping; Chen, Qiong; Wang, Suhua; Zhao, Wei; Han, Linzi; Yin, Yu; Xu, Ruyue; Zhang, Min; Cai, Chunlin; Wang, Deguang; Zang, Dandan; Zhou, Guoling; Zhou, Haisheng (2025-02-11). "G protein-coupled receptor 107 deficiency promotes development of diabetic nephropathy". Molecular Biomedicine. 6 (1): 10. doi:10.1186/s43556-025-00250-1. ISSN 2662-8651. PMC 11814420. PMID 39932642.
  7. ^ a b c Xu, Ruyue; Liang, Jiahui; Zhang, Shuyuan; Moru, Puseletso; Liao, Kainan; Xu, Deping; Cao, Guodong; Cai, Chunlin; Zang, Dandan; Zhou, Guoling; Ren, Min; Zhou, Haisheng (December 2025). "GPR107: A key driver of breast cancer invasion and metastasis through collagen IV modulation". Cancer Gene Therapy. 32 (12): 1414–1427. doi:10.1038/s41417-025-00977-7. ISSN 1476-5500.
  8. ^ a b Sáez-Martínez, Prudencio; Jiménez-Vacas, Juan M.; León-González, Antonio J.; Herrero-Aguayo, Vicente; Montero Hidalgo, Antonio J.; Gómez-Gómez, Enrique; Sánchez-Sánchez, Rafael; Requena-Tapia, María J.; Castaño, Justo P.; Gahete, Manuel D.; Luque, Raúl M. (2020-06-02). "Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer". Journal of Clinical Medicine. 9 (6): 1703. doi:10.3390/jcm9061703. ISSN 2077-0383. PMC 7355908. PMID 32498336.
  9. ^ Zhu, Xiaoling; Hu, Nan; Chen, Xiyao; Zhu, Miao-Zhang; Dong, Hailong; Xu, Xihui; Luo, Fuling; Hua, Yinan; Nair, Sreejayan; Samson, Willis K.; Xiong, Lize; Ren, Jun (2014). "Neuronostatin Attenuates Myocardial Contractile Function through Inhibition of Sarcoplasmic Reticulum Ca2+-ATPase in Murine Heart". Cellular Physiology and Biochemistry. 33 (6): 1921–1932. doi:10.1159/000362969. ISSN 1421-9778. Archived from the original on 2024-07-11.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.